Reply to Julie Steinestel, Christof Bernemann, Andres J. Schrader, and Jochen K. Lennerz's Letter to the Editor re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men with Metastatic Castration-resistant Prostate Cancer Treated with First- and Second-line Abiraterone and Enzalutamide. J Clin Oncol 2017;35:2149-56. AR-V7 Testing: What's in it for the Patient?: Estimating the Clinical Utility of Blood-based AR-V7 Testing in Prostate Cancer

Eur Urol. 2017 Dec;72(6):e170-e171. doi: 10.1016/j.eururo.2017.06.032. Epub 2017 Jul 8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Androstenes
  • Benzamides
  • Drug Resistance, Neoplasm
  • Humans
  • Male
  • Neoplastic Cells, Circulating*
  • Nitriles
  • Phenylthiohydantoin / analogs & derivatives
  • Prostatic Neoplasms, Castration-Resistant
  • RNA, Messenger
  • Receptors, Androgen*

Substances

  • Androstenes
  • Benzamides
  • Nitriles
  • RNA, Messenger
  • Receptors, Androgen
  • Phenylthiohydantoin
  • enzalutamide
  • abiraterone